SB 53 Update: Understanding the Proposed 138 “Therapeutic Pharmacy” Licenses in SC

South Carolina’s ongoing discussion around medical cannabis legislation has brought renewed attention to Senate Bill 53 (SB 53) and its proposed regulatory framework. A key element of the bill is the creation of 138 “Therapeutic Pharmacy” licenses, which would allow approved businesses to dispense medical cannabis products to qualified patients across the state. The proposal reflects lawmakers’ efforts to create a system that improves patient access while maintaining strict regulatory oversight.

Unlike recreational cannabis programs in some states, SB 53 focuses entirely on medical use under physician supervision. In South Carolina’s proposed framework, dispensaries are referred to as therapeutic pharmacies to highlight their medical purpose rather than traditional retail cannabis sales. Understanding how these 138 licenses would function is important for patients, healthcare professionals, and industry stakeholders as the state’s medical cannabis policy evolves.

What does the SB 53 Bill propose?

SB 53 aims to create a well-organised medical cannabis program in South Carolina. The bill describes the way cannabis-based treatment might be prescribed by doctors and delivered out of licensed therapeutic pharmacies.

Key Elements of the Proposal

The system would operate under several important provisions:

• The state would license 138 therapeutic pharmacies in South Carolina.

• These would be the official dispensing locations of approved medical cannabis products.

• Products would be sold only to patients who had a valid physician certification of qualifying conditions.

• All therapeutic pharmacies would be under strict regulatory control.

• The cannabis products would go through a controlled supply chain, which would be safe, tested, and labelled.

This is aimed at developing a regulated medical system that focuses on patient care while being accountable and transparent. To know more about the broader medical cannabis framework proposed in South Carolina, read this article: The 2026 South Carolina Compassionate Care Act: What’s Different This Session?

Why the Number 138 Matters?

One of the most discussed sections of SB 53 is the proposal of 138 therapeutic pharmacy licenses. Lawmakers chose this number to make it more accessible while also regulating.

1.   Balancing Access and Regulation

Permitting a small number of dispensing facilities may result in problems with obtaining medical cannabis products, especially in rural settings. Simultaneously, the problem of excessive license issuance may complicate supervision.

By limiting the number to 138, the proposal will ensure a manageable statewide network that patients can still access when necessary. To know more about the policy debate surrounding medical cannabis in South Carolina, read this article: SC Policy: Medical Cannabis vs. Hemp: Explaining the Legislative Tug-of-War in Columbia.

2. Geographic Distribution

The other important factor would be the distribution of licenses within the state. It is aimed at preventing the concentration of therapeutic pharmacies in large cities. The licensing structure is intended to promote regional accessibility, helping ensure that patients in both urban and rural settings can receive treatment without unnecessary travel.

How Therapeutic Pharmacies Would Operate?

The therapeutic pharmacies would operate within a highly controlled medical framework rather than in the traditional retail setting. Their major responsibility would be to administer physician-approved cannabis therapy to deserving patients.

Licensing and Oversight

To establish a therapeutic pharmacy, a business would be required to fulfil various regulatory requirements, including:

• Securing a state-licensed license through the application procedure.

• Incorporating security systems to secure products and patient records.

• Keeping an inventory record and reporting.

• Following strict product storage, handling, and labelling rules

State authorities would oversee these operations to ensure compliance with the rules established under SB 53. To know more about the legislative background and progress of the South Carolina medical cannabis bill, read this article: Columbia’s 2026 Session: Is S.53 the Final Hope for SC Medical Patients?

Role in Patient Care

The last phase of the medical cannabis supply chain would be therapeutic pharmacies. Patients may visit such licensed premises to get licensed products after being certified by a qualified physician.

The therapeutic pharmacy staff would also assist patients in using it and address safety issues within the program's medical framework.

Potential Benefits of the Proposed Licensing System

The proponents of SB 53 think the therapeutic pharmacy model may offer several benefits to the patients and the healthcare system.

• Greater treatment options: The eligible patients will have the opportunity to access cannabis-based treatments.

• Strong regulatory control: With a limited number of licenses, a small number of regulators can monitor operations more effectively.

• Product safety standards: A regulated supply chain provides testing, labelling, and quality control.

• Economic prospects: The program has the potential to generate employment and a medical cannabis business in the state.

Its supporters believe that a well-organised program could help both care for patients and develop a responsible industry. To know more about federal actions affecting hemp-derived products and cannabis regulations, read this article: What the FDA’s Crackdown Means for Hemp-Derived Products & Retailers?

Ongoing Debate Around the Proposal

SB53, although a designed bill, is still causing debate among the legislators and citizens in South Carolina.

Advocates think that the bill presents a well-regulated solution to access to medical cannabis, concentrating on physician regulation and limited distribution through therapeutic pharmacies. However, not all policymakers are as confident, and they are worried about regulation, implementation, and the level of patient demand, considering the suggested 138-license limit.

Since lawmaking processes are still ongoing, the bill's final form might change as parliamentarians consider suggestions and potential revisions. To know more about recent regulatory developments affecting hemp laws in the state, read this article:

Conclusion

A proposal to develop 138 therapeutic pharmacy licenses under SB 53 in South Carolina is a major step in the state's medical cannabis policy debate. The bill is expected to make access to cannabis-based treatments available to patients controlled by means of a well-regulated distribution system.

Therapeutic pharmacies would be licensed venues where qualified patients can access approved products under the supervision of a medical supervisor, if implemented. The proposed licensing cap reflects lawmakers’ efforts to balance patient access with responsible oversight as the state continues to evaluate its medical cannabis framework. 

For more updates and insights on cannabis policy, hemp regulations, and industry developments, visit CBHD News.